The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled. Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Construction contracts for major national general contractor
Represented numerous general contractors on construction of several facilities at a university, including: (a) Field Renovation and Expansion: We more
Executive compensation and employee benefits matters for a Massachusetts bank holding company
Represents a Massachusetts bank holding company on executive compensation and employee benefits matters, including matters related to employee stock more
Wrongful termination of multi-year workers' compensation insurance program
The firm served as lead counsel in litigation alleging breach of a contract to provide three years of “guaranteed cost” workers compensation more
Pan American World Airways Inc. v. Flight 001 Inc.
Defeated a motion for a preliminary injunction brought by Pan American World Airways against our clients Flight 001, Inc. and Flight 001 Holdings, more